Update from FSHD drug screening programme

Published Date
21/03/2019
Author
Beatriz Bustillo Ramirez
Category
Research
Orange box stating: Breaking news research

Facio Therapies announced today that it has completed a comprehensive search for new FSHD drug candidates. The company has identified 100+ compounds that show some level of activity in lab tests. The next step will be to prioritise the most promising compounds to investigate in more detail.

For more information, read Facio’s press release.

If you have any questions about this news story or any other FSHD research, please contact the MDUK Research Line on 020 7803 4813 or email research@musculardystrophyuk.org.

Keep in touch